High-molecular weight compounds of nitrogen and sulfur as therapeutic agents

Thumbnail Image
Date
1946
Authors
Massie, Samuel
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Altmetrics
Authors
Research Projects
Organizational Units
Organizational Unit
Journal Issue
Is Version Of
Versions
Series
Department
Chemistry
Abstract

General reviews of the chemotherapy of malaria and tuberculosis have been made;A survey of the physiological properties and therapeutic uses of compounds containing high-molecular weight aliphatic groups has been given;The large amount of lipoidal tissue present in certain strains of bacteria, such as the tubercle bacillus, suggested that the introduction into potential physiologically-active structures of groups which would be lipoidal-soluble might give rise to valuable medicinals. This thought initiated the study and preparation of nitrogen and sulfur compounds containing high-molecular weight aliphatic groups as therapeutic agents;Several nitrogen derivatives have been made for therapeutic testing, These agents include dibutylalkylamines derivatives of tetradecylamine and hexadecylamine. Rearrangement has been shown to occur during the reaction between alpha-halogenonaphthalenes and lithium dialkylamides, beta-dialkylaminonaphthalenes being formed;Several sulfur derivatives containing high-molecular weight aliphatic groups have been prepared for pharmacological testing. These compounds include quinolyl dodecyl sulfides, hydroxy sulfides, imidosulfides and sulfur-containing mercurials;The reaction between laurophenone and phosphorus pentachloride has been shown to give 1-phenyl-1-chlorododeceno-1 in good yield;Several miscellaneous compounds have been prepared for physiological testing. These compounds include anils derived from 1-diethylamino-4-aminopentane, substituted cinchoninic acids and phenothiazine derivatives;Complete pharmacological results are not available, but none of the commands on which reports have been received has shown any significant therapeutic activity.

Comments
Description
Keywords
Citation
Source
Subject Categories
Copyright
Tue Jan 01 00:00:00 UTC 1946